RINGER'S INJECTION,

RINGER'S INJECTION LACTATED USP in 1000ML units, packaged 12 per pack, is being procured under contract SPE2DP-26-T-3134 with a total quantity of 10 packs, requiring delivery within five days to FPO AP 96673, with FOB destination terms and no variance allowed in quantity. The item is regulated by the FDA and has a non-extendable shelf life of 30 months, with storage recommended at room temperature (25°C) though brief exposure to 40°C is acceptable. All packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and conform to DLA Packaging Requirements for Procurement, including commercial exterior containers suitable for safe carrier transport at the lowest cost. The product must be marked and labeled per MMS No. 1 guidelines and packaged in accordance with ASTM D3951 unless classified as hazardous under FED-STD-313, in which case IP025 requirements apply. Technical and quality requirements from the DLA Master List take precedence over any commercial standards. The manufacturer is B. BROWN MEDICAL INC with NDC 00264-7750-00, and the NSN is 6505013306267. Delivery must occur no later than April 22, 2026, and all shipments are subject to DLA logistics protocols including VSM for RDD 999 NMCS shipments and vessel transportation procedures. Government use only data and point of contact details are provided for contract administration.